Come hear David Anderson, PhD speak at SCOPE on Tuesday February 13th at 5:30pm.  David will be presenting Clinical ink’s latest offering, GlucoseReady™: A Digital Platform for Assessing Behavior, Glucose, Symptoms, and Biometrics in Cardiometabolic Disease.